CASR and neonatal severe primary hyperparathyroidism: Notably, heterozygous versus pure mutations in the CASR gene exhibit different thresholds for calcium and PTH levels in neonatal severe PHPT (NSHPT), and serum calcium >4.5 mM may serve as a reliable biomarker for the diagnosis of pure mutations (61).